Opko Health, Inc. (OPK) stock forecast and price target
Price $1.68 · data as of November 13, 2026
12-month price target
Average target$4.15
Upside / downside+147.0%
Analysts5
ConsensusBuy
Low $2.25Average $4.15High $8.50
Gold marker: average target · white marker: today’s price ($1.68)
Analyst ratings
Strong buy 3Buy 2Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.24 | — | $421M |
| Next fiscal year ends December 31, 2027 | $-0.34 | −36.7% | $328M |
| Next quarter ends December 31, 2026 | $-0.04 | +2.2% | $68M |
| Quarter after ends March 31, 2027 | $-0.11 | — | $80M |
Consensus of the analysts covering Opko Health, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the Opko Health stock price target?
The average 12-month target from 5 analysts is $4.15, 147.0% above the current price of $1.68 Targets range from $2.25 to $8.50.
Is Opko Health a buy according to analysts?
The consensus rating is “Buy” (3 strong buy, 2 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Opko Health expected to earn?
Analysts expect EPS of $-0.24 for the fiscal year ending December 31, 2026 and $-0.34 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.